These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7979271)

  • 1. Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice.
    Klemens SP; Cynamon MH
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1455-9. PubMed ID: 7979271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice.
    Cynamon MH; Klemens SP; Grossi MA
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1452-4. PubMed ID: 7979270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice.
    Klemens SP; Cynamon MH
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1721-5. PubMed ID: 7986001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of azithromycin against Mycobacterium avium infection in beige mice.
    Cynamon MH; Klemens SP
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1611-3. PubMed ID: 1329622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
    Cynamon MH; Carter JL; Shoen CM
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2895-6. PubMed ID: 10991883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin.
    Vrioni G; Nauciel C; Kerharo G; Matsiota-Bernard P
    J Antimicrob Chemother; 1998 Oct; 42(4):483-7. PubMed ID: 9818747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.
    Bermudez LE; Petrofsky M; Kolonoski P; Young LS
    Antimicrob Agents Chemother; 1998 Jan; 42(1):180-3. PubMed ID: 9449283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex.
    Klemens SP; Grossi MA; Cynamon MH
    Antimicrob Agents Chemother; 1994 Feb; 38(2):234-7. PubMed ID: 8192449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence and drug susceptibility of Mycobacterium celatum.
    Fattorini L; Baldassarri L; Li YJ; Ammendolia MG; Fan Y; Recchia S; Iona E; Orefici G
    Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2733-2742. PubMed ID: 11065352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.
    Brown BA; Wallace RJ; Onyi GO
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1987-90. PubMed ID: 1416891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin.
    Tartaglione T
    Clin Ther; 1997; 19(4):626-38; discussion 603. PubMed ID: 9377608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
    Cynamon MH; Klemens SP; Swenson CE
    J Antimicrob Chemother; 1992 Jun; 29(6):693-9. PubMed ID: 1387133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
    Klemens SP; DeStefano MS; Cynamon MH
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2413-7. PubMed ID: 1336945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.
    Bauernfeind A; Jungwirth R; Eberlein E
    Infection; 1995; 23(5):316-21. PubMed ID: 8557398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice.
    Fattorini L; Xiao Y; Mattei M; Li Y; Iona E; Thoresen OF; Orefici G
    Microb Drug Resist; 1999; 5(3):227-33. PubMed ID: 10566874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection.
    Valero G; Moreno F; Graybill JR
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2676-7. PubMed ID: 7872769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus.
    De Groote MA; Johnson L; Podell B; Brooks E; Basaraba R; Gonzalez-Juarrero M
    J Antimicrob Chemother; 2014 Apr; 69(4):1057-64. PubMed ID: 24222613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of
    Lanoix JP; Joseph C; Peltier F; Castelain S; Andréjak C
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice.
    Lounis N; Truffot-Pernot C; Bentoucha A; Robert J; Ji B; Grosset J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3229-30. PubMed ID: 11600387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.